O. Decaux

1.2k total citations
45 papers, 704 citations indexed

About

O. Decaux is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, O. Decaux has authored 45 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Hematology and 10 papers in Genetics. Recurrent topics in O. Decaux's work include Multiple Myeloma Research and Treatments (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). O. Decaux is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). O. Decaux collaborates with scholars based in France, United States and United Kingdom. O. Decaux's co-authors include P. Jégo, B. Grosbois, C. Cazalets, S. Jouneau, F. Jouen, S. Josse, C. Landron, Jean-François Ménard, S. Dominique and Élisabeth Diot and has published in prestigious journals such as Annals of the Rheumatic Diseases, Leukemia and Lara D. Veeken.

In The Last Decade

O. Decaux

42 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Decaux France 13 274 268 200 164 145 45 704
Pascal Godmer France 13 81 0.3× 321 1.2× 187 0.9× 189 1.2× 157 1.1× 31 802
Chelsea Bentow United States 21 271 1.0× 131 0.5× 562 2.8× 121 0.7× 76 0.5× 52 969
Sandra Muñoz Spain 6 163 0.6× 153 0.6× 428 2.1× 39 0.2× 94 0.6× 7 805
Bouchra Asli France 15 167 0.6× 154 0.6× 259 1.3× 618 3.8× 358 2.5× 30 1.1k
Keisuke Nishimura Japan 15 161 0.6× 249 0.9× 151 0.8× 111 0.7× 27 0.2× 74 682
Ippei Miyagawa Japan 16 90 0.3× 96 0.4× 549 2.7× 81 0.5× 120 0.8× 72 904
Taro Iwamoto Japan 13 125 0.5× 201 0.8× 513 2.6× 123 0.8× 85 0.6× 41 933
Yusuke Miyazaki Japan 16 106 0.4× 87 0.3× 628 3.1× 88 0.5× 119 0.8× 60 993
Ziyan Wu China 14 115 0.4× 87 0.3× 278 1.4× 128 0.8× 97 0.7× 68 638
Masako Otani Japan 12 76 0.3× 124 0.5× 98 0.5× 123 0.8× 36 0.2× 67 517

Countries citing papers authored by O. Decaux

Since Specialization
Citations

This map shows the geographic impact of O. Decaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Decaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Decaux more than expected).

Fields of papers citing papers by O. Decaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Decaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Decaux. The network helps show where O. Decaux may publish in the future.

Co-authorship network of co-authors of O. Decaux

This figure shows the co-authorship network connecting the top 25 collaborators of O. Decaux. A scholar is included among the top collaborators of O. Decaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Decaux. O. Decaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bahlis, Nizar J., Alessandro Corso, P. Desjardins, et al.. (2017). Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial. Leukemia. 31(11). 2435–2442. 14 indexed citations
2.
Fouquet, Guillemette, Margaret Macro, O. Decaux, et al.. (2015). Le pomalidomide dans le myélome multiple. La Revue de Médecine Interne. 36(9). 613–618. 1 indexed citations
3.
Duvauferrier, R, et al.. (2013). Current role of CT and whole body MRI in multiple myeloma. Diagnostic and Interventional Imaging. 94(2). 169–183. 14 indexed citations
4.
Barbarot, S., A. Néel, J. Connault, et al.. (2013). Manifestations cutanées associées aux gammapathies monoclonales. La Revue de Médecine Interne. 35(1). 28–38. 1 indexed citations
5.
Saadoun, David, Vincent Thibault, M. Longuet, et al.. (2013). Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Annals of the Rheumatic Diseases. 73(5). 831–837. 57 indexed citations
6.
Charles, Pierre, A. Néel, N. Tieulié, et al.. (2013). Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Lara D. Veeken. 53(3). 532–539. 90 indexed citations
7.
Ito, Marie, S. Josse, O. Decaux, et al.. (2012). Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmunity Reviews. 11(10). 739–745. 147 indexed citations
8.
Durant, C., Johan van der Lei, Anne‐Sophie Moreau, et al.. (2012). La Schtroumpfette en Australie. La Revue de Médecine Interne. 33(9). 536–538.
9.
Saadoun, David, Marc Pineton de Chambrun, Olivier Hermine, et al.. (2012). Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma. Arthritis Care & Research. 65(4). 643–647. 32 indexed citations
10.
Magrangeas, Florence, Hervé Avet‐Loiseau, Wilfried Gouraud, et al.. (2012). Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 27(2). 473–481. 83 indexed citations
11.
Decaux, O., et al.. (2012). Neuropathies associées à une IgM monoclonale anti-MAG. La Revue de Médecine Interne. 33(12). 686–692. 2 indexed citations
13.
Millet, Arnaud, O. Decaux, Benoît Guillet, et al.. (2007). Efficacité du rituximab dans les hémophilies acquises : à propos de deux cas et revue de la littérature. La Revue de Médecine Interne. 28(12). 862–865. 6 indexed citations
14.
Decaux, O., Laurence Lodé, Stéphane Minvielle, & Hervé Avet‐Loiseau. (2007). Anomalies génétiques dans le myélome : rôle dans l'oncogenèse et implications pronostiques. La Revue de Médecine Interne. 28(10). 677–681. 3 indexed citations
15.
Revest, Matthieu, et al.. (2006). Aortites thoraciques infectieuses : implications microbiologiques, physiopathologiques et thérapeutiques. La Revue de Médecine Interne. 28(2). 108–115. 48 indexed citations
16.
Revest, Matthieu, O. Decaux, T. Frouget, et al.. (2005). Les aortites syphilitiques. Expérience d'un service de médecine interne. La Revue de Médecine Interne. 27(1). 16–20. 13 indexed citations
17.
Revest, Matthieu, O. Decaux, T. Frouget, et al.. (2005). Infections à cryptocoque chez des patients non VIH. À propos de quatre cas et revue de la littérature. La Revue de Médecine Interne. 27(3). 203–208. 12 indexed citations
18.
Cazalets, C., O. Decaux, M.P. Ramée, et al.. (2003). Épidémiologie descriptive des amyloses diagnostiquées au CHU de Rennes de 1995 à 1999. La Revue de Médecine Interne. 24(7). 424–430. 7 indexed citations
19.
Decaux, O., et al.. (2002). Gammapathie monoclonale de signification indéterminée : suivi évolutif de 51 patients âgés de plus de 70 ans. La Revue de Médecine Interne. 23(9). 751–758. 2 indexed citations
20.
Decaux, O., et al.. (2002). Traitement des hématomes sous-duraux chroniques par les corticoïdes : à propos de deux observations. La Revue de Médecine Interne. 23(9). 788–791. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026